ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cellsMOUSLI, M; HOPFNER, R; ABBADY, A-Q et al.British journal of cancer. 2003, Vol 89, Num 1, pp 120-127, issn 0007-0920, 8 p.Article

Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesisULRICH, Sandra; WOLTER, Freya; STEIN, Jürgen M et al.Molecular nutrition & food research (Print). 2005, Vol 49, Num 5, pp 452-461, issn 1613-4125, 10 p.Article

Cell cycle and no endTESSEMA, Mathewos; LEHMANN, Ulrich; KREIPE, Hans et al.Virchows Archiv. 2004, Vol 444, Num 4, pp 313-323, issn 0945-6317, 11 p.Article

Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosisNAKAYAMA, Satoshi; MIYOSHI, Yasuo; ISHIHARA, Hideki et al.Breast cancer research and treatment. 2008, Vol 112, Num 3, pp 405-410, issn 0167-6806, 6 p.Article

AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinibMAIELLO, Monica R; D'ALESSIO, Amelia; DE LUCA, Antonella et al.Breast cancer research and treatment. 2007, Vol 102, Num 3, pp 275-282, issn 0167-6806, 8 p.Article

Design and synthesis of N-methylmaleimide indolocarbazole bearing modified 2-acetamino acid moieties as Topoisomerase I inhibitorsZHIYU LI; FUMING ZHAI; LI ZHAO et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 2, pp 406-409, issn 0960-894X, 4 p.Article

Multi-objective multi-drug scheduling schemes for cell cycle specific cancer treatmentALAM, M. S; HOSSAIN, M. A; ALGOUL, S et al.Computers & chemical engineering. 2013, Vol 58, pp 14-32, issn 0098-1354, 19 p.Article